Literature DB >> 21494929

[Evidence-based information concerning increasing age in German guideline portals: comparison using heart failure as an example].

B Weiss1.   

Abstract

The ongoing epidemiological and demographic developments lead to a greater demand for evidence-based information for the practice in health-care provision. Therefore, it was evaluated whether older patients are playing a role in German guidelines, whether there are guidelines on diseases with particular relevance in old age, whether elderly patients are particularly considered in guidelines, and whether the information available in guidelines is easily retrieved. First, an overview is given on portals for guidelines in Germany with free online access. Then, selected results from an analysis of information specifically considering elderly patients of selected registers are presented. There was a lack of information regarding older patients in all guidelines analyzed, apart from the few guidelines specifically addressing old age. Explicit statements explaining the reasons for the lack of information are rare in guidelines. The user of the guidelines, therefore, remains uninformed whether this is because of the lack of available data. From the users' point of view, there should be an online platform providing the complete evidence via shared access. This would clearly improve the overview, thus, facilitating the search for specific issues, e.g., older age and multimorbidity. In addition, there is room for improvement in practical aspects of the use of guidelines, e.g., the standardization of guideline forms and the consolidation of individual guideline portals would clearly assist persons wishing to obtain an overview. Furthermore, most guidelines do not have internal links between content, references, explanation of evidence-based information, and recommendations, which are necessary for effective research.

Entities:  

Mesh:

Year:  2011        PMID: 21494929     DOI: 10.1007/s00391-011-0175-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  7 in total

Review 1.  [Practice guidelines in medicine--validity for clinical application?].

Authors:  G Ollenschläger; H Kirchner; M Fiene
Journal:  Internist (Berl)       Date:  2001-04       Impact factor: 0.743

2.  [Decisions of the Federal Joint Committee for rejecting work with "weak" or failing evidence].

Authors:  Anja Schwalm; Matthias Perleth; Katja Matthias
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2010

3.  Need for evidence-based recommendations in guidelines with relevance to healthcare provision in older patients in Germany.

Authors:  Benjamin Weiss; Wolfgang von Renteln-Kruse
Journal:  J Am Geriatr Soc       Date:  2010-07       Impact factor: 5.562

Review 4.  Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

Authors:  Joseph Watine; Bruno Friedberg; Eva Nagy; Rita Onody; Wytze Oosterhuis; Peter S Bunting; Jean-Christophe Charet; Andrea Rita Horvath
Journal:  Clin Chem       Date:  2006-01       Impact factor: 8.327

5.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions.

Authors:  Mary E Tinetti; Sidney T Bogardus; Joseph V Agostini
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

6.  The need for collaboration in guidelines.

Authors:  Jako S Burgers
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2009

7.  Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries.

Authors:  Jako S Burgers; Julia V Bailey; Niek S Klazinga; Akke K Van Der Bij; Richard Grol; Gene Feder
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

  7 in total
  1 in total

1.  The rediscovery of the social side of medicine: philosophy and value of the International Classification of Functioning, Disability and Health (ICF).

Authors:  Wolfgang Seger
Journal:  Electron Physician       Date:  2018-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.